Early stage diagnosis of oral cancer using 1H NMR-Based metabolomics1,2

Neoplasia

Volumn 11, Issue 3, 2009, Pages 269-276

  Tiziani, Stofino ^a   Lopes, Victor ^b   Günther, Ulrich L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; CHEMOMETRIC ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLITE; METABOLOMICS; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 62549138339     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.81396     Document Type: Article

References (46)

1. Boyle P and Ferlay J (2005). Cancer incidence and mortality in Europe, 2004. Ann Oncol 16, 481-488.
2. Ferlay J, Autiet P, Boniol M, Heanue M, Colombet M, and Boyle P (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18, 581-592.
3. Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, and Wang BY (2005). Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol29, 167-178.
4. Carvalho AL, Nishimoto IN, Califano JA, and Kowalski LP (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer114, 806-816.
5. Beckwith-Hall BM, Thompson NA, Nicholson JK, Lindon JC, and Holmes E (2003). A metabonomic investigation of hepatotoxicity using diffusion-edited H-l NMR spectroscopy of blood serum. Analyst128, 814-818.
6. Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, and Holmes E (2003).Application of chemometrics to H-l NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 128, 32-36.
7. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, Zanconato S, Guillou C, and Baraldi E (2007). Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 175, 986-990.
8. Duarte IF, Goodfellow BJ, Barros A, Jones JG, Barosa C, Diogo L, Garcia P, and Gill AM (2007). Metabolic chatacterisation of plasma in juveniles with glycogen storage disease type la (GSDla) by high-resolution H-l NMR spectroscopy.NMR Biomed 20, 401-412.
9. Makinen VP, Soininen P Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop PH, and Ala-Korpela M (2006). Diagnosing diabetic nephropathy by H-l NMR metabonomics of serum. Magn Reson Mat Phys Biol Med19, 281-296.
10. Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J,Geisler JP, Miller G, Sellers T, Cliby W, et al. (2005). Detection of epithelial ovarian cancer using H-l-NMR-based metabonomics. IntJ Cancer113,782-788.
11. Stubbs M, Robinson SP, Hui C, Price NM, Rodrigues LM, Howe FA, and Griffiths JR (2002). The importance of tumor metabolism in cancer prognosis and therapy; pre-linical studies on rodent tumors with agents that improve tumor oxygenation. Oxford, England: Pergamon-Elsevier Science Ltd, pp. 131-141.
12. Tsang TM, Huang JTJ, Holmes E, and Bahn S (2006). Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. J Proteome Res 5,756-760.
13. Whitehead TL and Kieber-Emmons T (2005). Applying in vitro NMR spectroscopy and H-l NMR metabonomics to breast cancer characterization and detection. Prog Nucl Magn Reson Spectrosc 47, 165-174.
14. Adalsteinsson E, Spielman DM, Pauly JM, Terris DJ, Sommer G, and Macovski A (1998). Feasibility study of lactate imaging of head and neck tumors. NMR Biomed 11, 360-369.
15. Arias-Mendoza F, Payne GS, Zakian KL, Schwarz AJ, Stubbs M, Stoyanova R, Ballon D, Howe FA, Koutcher JA, Leach MO, et al. (2006). In vivo P-31 MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. NMR Biomed 19, 504-512.
16. Bezabeh T, Odium O, Nason R, Kerr P, Sutherland D, Patel R, and Smith ICP (2005). Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. Am J Neuroradiol26, 2108-2113.
17. El-Sayed S, Bezabeh T, Odium O, Patel R, Ahing S, MacDonald K, Somorjai RL, and Smith ICP (2002). An ex vivo study exploring the diagnostic potential of H-l magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck J Set Spec 24, 766-772.
18. Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, and Castillo M (2000). The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy.Am J Neuroradiol 21, 1930-1935.
19. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, and Blackstock W (1997). Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. Am J Neuroradiol 18, 1057-1072.
20. Star-Lack JM, Adalsteinsson E, Adam MF, Terris DJ, Pinto HA, Brown JM, and Spielman DM (2000). In vivo H-l MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. Am J Neuroradiol 21, 183-193.
21. Yokota H, Guo JF, Matoba M, Higashi K, Tonami H, and Nagao Y (2007). Lactate, choline, and creatine levels measured by vitro H-l-MRS as prognostic parameters in patients with non-small-cell lung cancer. J Magn Reson Imaging 25, 992-999.
22. Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W and Whiteside TL (2003). Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015-1024.
23. Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, Sato F, Fujimoto K, Sasaki N, Ikeda MA, et al. (2005). Association of expression of receptot for advanced glycation end products and invasive activity of otal squamous cell carcinoma. Oncology 69, 246-255.
24. Ujpal M, Barabas J, Kovalszky I, Szabo G, Nemeth Z, Gabris K, and Suba ZS (2007). A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy. J Oral Maxillofac Surg 65, 452-456.
25. Greene FL, Page DL, and Fleming ID (2002). AJCC Cancer Staging Manual. Philadelphia, PA: Lippincott Raven.
26. Tiziani S, Emwas AH, Lodi A, Ludwig C, Bunce CM, Viant MR, and Gunther UL (2008). Optimized metabolite extraction from blood serum for H-l nuclear magnetic resonance spectroscopy. Anal Biochem 377, 16-23.
27. Aue W, Karhan J, and Ernst R (1976). Homonuclear broad-band decoupling and 2-dimensional J-resolved NMR spectroscopy. J Chem Phys 64, 4226-227.
28. Hwang TL and Shaka AJ (1995). Water suppression that works-excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson A 112, 275-279.
29. Thrippleton MJ, Edden RAE, and Keeler J (2005). Suppression of strong coupling artefacts in J-spectra. J Magn Reson 174, 97-109.
30. Hurd RE, John BK, and Plant HD (1991). Novel method for detection of pure-phase, double-absorption lineshapes in gradient-enhanced spectroscopy. J Magn Reson 93, 666-670.
31. Gunther UL, Ludwig C, and Ruterjans H (2000). NMRLAB-advanced NMR data processing in MATLAB. J Magn Reson 145, 201-208.
32. Parsons HM, Ludwig C, Gunther UL, and Viant MR (2007). Improved classification accuracy in 1 - and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation. BMC Bioinformalics. 8, 234.
33. Tiziani S, Lodi A, Ludwig C, Parsons HM, and Viant MR (2008). Effects of the application of different window functions and projection methods on processing of H-l J-resolved nuclear magnetic resonance spectra for metabolomics. Anal Chim Acta 610, 80-88.
34. Viant MR (2003). Improved methods for the acquisition and interpretation of NMR metabolomic data. BMC Bioinformalics 310, 943-948.
35. Morvan D and Demidem A (2007). Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Cancer Res 67, 2150-2159.
36. Lai HS, Lee JC, Lee PH, Wang ST, and Chen WJ (2005). Plasma free amino acid profile in cancer patients. Semin Cancer Biol 15, 267-276.
37. Newman E, Heslin MJ, Wolf RF, Pisters PWT, and Brennan MF (1992). The effect of insulin on glucose and protein metabolism in the forearm of cancer patients. Surg Oncol 1, 257-267.
38. Pisters PWT and Brennan MF (1990). Amino-acid-metabolism in human cancer cachexia. Annu Rev Nulr 10, 107-132.
39. Pisters PWT, Cersosimo E, Rogatko A, and Brennan MF (1992). Insulin action on glucose and branched-chain amino-acid-metabolism in cancer cachexia-differential-effects of insulin. Surgery 111, 301-310.
40. Bongaerts GPA, van Hatteren HK, Verhagen CAM, and Wagener DJT (2006). Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism. Med Hypotheses 67, 1213-1222.
41. Lardy HA, Paetkau V, and Walter P (1965). Paths of carbon in gluconeogenesis and lipogenesis-role of mitochondria in supplying precursors of phosphoenol-pyruvate. Proc Natl Acad Sci USA 53, 1410-1415.
42. Lowry SF, Foster DM, Norton JA, Berman M, and Brennan MF (1981). Glucose disposal and gluconeogenesis from alanine in tumor-bearing Fischer-344 rats. J Natl Cancer Inst 66, 653-658.
43. Garber K (2004). Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96, 1805-1806.
44. Kubota A, Meguid MM, and Hitch DC (1992). Amino-acid profiles correlate diagnostically with organ site in 3 kinds of malignant-tumors. Cancer 69, 2343-2348.
45. Ching N, Grossi C, Jham G, Angers J, Zurawinsky H, Ching CY, and Nealon TF (1984). Plasma amino-acid and serum unesterified fatty-acid deficits and the effect of nutritional support in chemotherapy treatment. Surgery 95,730-738.
46. Miller BL (1991). A review of chemical issues in H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4, 47-52.